These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 10400403)

  • 21. Pharmacological therapies for obesity.
    Kaplan LM
    Gastroenterol Clin North Am; 2005 Mar; 34(1):91-104. PubMed ID: 15823441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug therapy for obesity in the elderly.
    Dvorak R; Starling RD; Callés-Escandon J; Sims EA; Poehlman ET
    Drugs Aging; 1997 Nov; 11(5):338-51. PubMed ID: 9359021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological and clinical studies of ephedrine and other thermogenic agonists.
    Astrup A; Breum L; Toubro S
    Obes Res; 1995 Nov; 3 Suppl 4():537S-540S. PubMed ID: 8697055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity: pathophysiology and clinical management.
    Gurevich-Panigrahi T; Panigrahi S; Wiechec E; Los M
    Curr Med Chem; 2009; 16(4):506-21. PubMed ID: 19199918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orlistat and sibutramine beyond weight loss.
    Mannucci E; Dicembrini I; Rotella F; Rotella CM
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):342-8. PubMed ID: 17928208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A role for olestra in body weight management.
    Eldridge AL; Cooper DA; Peters JC
    Obes Rev; 2002 Feb; 3(1):17-25. PubMed ID: 12119656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A risk-benefit assessment of anti-obesity drugs.
    Kolanowski J
    Drug Saf; 1999 Feb; 20(2):119-31. PubMed ID: 10082070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The pharmacological treatment of obesity: past, present and future].
    Simonyi G; Pados G; Medvegy M; Bedros JR
    Orv Hetil; 2012 Mar; 153(10):363-73. PubMed ID: 22370224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options.
    Fujioka K
    Obes Res; 2002 Dec; 10 Suppl 2():116S-123S. PubMed ID: 12490660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cerebrospinal fluid/serum leptin ratio during pharmacological therapy for obesity.
    Rodrigues AM; Radominski RB; Suplicy Hde L; De Almeida SM; Niclewicz PA; Boguszewski CL
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1621-6. PubMed ID: 11932292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges in obesity management.
    Poston WS; Foreyt JP; Borrell L; Haddock CK
    South Med J; 1998 Aug; 91(8):710-20. PubMed ID: 9715214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients.
    Finer N; Ryan DH; Renz CL; Hewkin AC
    Diabetes Obes Metab; 2006 Mar; 8(2):206-13. PubMed ID: 16448525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-obesity drugs: what does sibutramine offer? An analysis of its potential contribution to obesity treatment.
    Van Gaal LF; Wauters MA; De Leeuw IH
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():35-40. PubMed ID: 9792480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug therapy of obesity].
    Wechsler JG
    Acta Med Austriaca; 1998; 25(4-5):138-41. PubMed ID: 9879389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy of obesity: an update.
    Schurgin S; Siegel RD
    Nutr Clin Care; 2003; 6(1):27-37. PubMed ID: 12841428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Croatian experience with sibutramine in the treatment of obesity--multicenter prospective study.
    Stimac D; Ruzić A; Majanović SK
    Coll Antropol; 2004 Jun; 28(1):215-21. PubMed ID: 15636078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of antiobesity drugs.
    Cheung BM; Cheung TT; Samaranayake NR
    Ther Adv Drug Saf; 2013 Aug; 4(4):171-81. PubMed ID: 25114779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological treatment of obesity. Past, present, and future.
    Wangsness M
    Minn Med; 2000 Nov; 83(11):21-6. PubMed ID: 11126476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sibutramine, an upcoming drug for weight loss acting on energy consumption and energy expenditure].
    Astrup A
    Acta Med Austriaca; 1998; 25(4-5):146-9. PubMed ID: 9879391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anorexigen-induced cardiac valvulopathy and female gender.
    Naqvi TZ; Gross SB
    Curr Womens Health Rep; 2003 Apr; 3(2):116-25. PubMed ID: 12628081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.